Pharma executives shower Bill Cassidy with campaign cash

WASHINGTON — Sen. Bill Cassidy’s new perch as the top Republican on the Senate health committee has attracted some attention — and some campaign cash — from the executives of pharmaceutical companies, federal disclosures show.

The slew of campaign donations from drug industry executives came about a week after Cassidy, a Louisiana Republican, officially became the ranking member of the Senate health committee.

The contributions all came on either Feb. 10 or 11, and included $5,800 from Pfizer CEO Albert Bourla, $5,000 from Eli Lilly CEO David Ricks, $2,900 from Bristol Myers Squibb CEO Giovanni Caforio, and $2,500 from Biogen CEO Christopher Viehbacher, all of whom sit on PhRMA’s board.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In